company background image
A142760 logo

MOA Life Plus KOSDAQ:A142760 Stock Report

Last Price

₩1.31k

Market Cap

₩49.3b

7D

3.5%

1Y

-36.0%

Updated

29 Nov, 2024

Data

Company Financials

MOA Life Plus Co. Ltd.

KOSDAQ:A142760 Stock Report

Market Cap: ₩49.3b

A142760 Stock Overview

Engages in the medicine and consumer business in South Korea. More details

A142760 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Does not have a meaningful market cap (₩49B)

Shareholders have been diluted in the past year


MOA Life Plus Co. Ltd. Competitors

Clinomics

KOSDAQ:A352770

₩20.3b

Genexine

KOSDAQ:A095700

₩265.6b

Xcell Therapeutics

KOSDAQ:A373110

₩52.6b

GENINUS

KOSDAQ:A389030

₩44.4b

Price History & Performance

Summary of all time highs, changes and price drops for MOA Life Plus
Historical stock prices
Current Share Price₩1,306.00
52 Week High₩4,500.00
52 Week Low₩1,221.00
Beta0.72
11 Month Change-4.11%
3 Month Change-24.68%
1 Year Change-35.98%
33 Year Change-84.53%
5 Year Change-78.31%
Change since IPO-90.80%

Recent News & Updates

Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

Oct 18
Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

There's No Escaping Bioleaders Corporation's (KOSDAQ:142760) Muted Revenues Despite A 30% Share Price Rise

Apr 19
There's No Escaping Bioleaders Corporation's (KOSDAQ:142760) Muted Revenues Despite A 30% Share Price Rise

Recent updates

Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

Oct 18
Health Check: How Prudently Does MOA Life Plus (KOSDAQ:142760) Use Debt?

There's No Escaping Bioleaders Corporation's (KOSDAQ:142760) Muted Revenues Despite A 30% Share Price Rise

Apr 19
There's No Escaping Bioleaders Corporation's (KOSDAQ:142760) Muted Revenues Despite A 30% Share Price Rise

Bioleaders Corporation's (KOSDAQ:142760) Business And Shares Still Trailing The Industry

Mar 01
Bioleaders Corporation's (KOSDAQ:142760) Business And Shares Still Trailing The Industry

Bioleaders' (KOSDAQ:142760) Shareholders Are Down 47% On Their Shares

Feb 16
Bioleaders' (KOSDAQ:142760) Shareholders Are Down 47% On Their Shares

Shareholder Returns

A142760KR BiotechsKR Market
7D3.5%0.9%1.1%
1Y-36.0%25.4%-4.0%

Return vs Industry: A142760 underperformed the KR Biotechs industry which returned 25.4% over the past year.

Return vs Market: A142760 underperformed the KR Market which returned -4% over the past year.

Price Volatility

Is A142760's price volatile compared to industry and market?
A142760 volatility
A142760 Average Weekly Movement5.9%
Biotechs Industry Average Movement8.2%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A142760 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A142760's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199949Andy Chulwww.moalifeplus.com

MOA Life Plus Co. Ltd. engages in the medicine and consumer business in South Korea. It offers P53, a target anti-cancer drug.

MOA Life Plus Co. Ltd. Fundamentals Summary

How do MOA Life Plus's earnings and revenue compare to its market cap?
A142760 fundamental statistics
Market cap₩49.28b
Earnings (TTM)-₩12.01b
Revenue (TTM)₩18.44b

2.7x

P/S Ratio

-4.1x

P/E Ratio

Is A142760 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A142760 income statement (TTM)
Revenue₩18.44b
Cost of Revenue₩12.88b
Gross Profit₩5.55b
Other Expenses₩17.56b
Earnings-₩12.01b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-318.35
Gross Margin30.11%
Net Profit Margin-65.16%
Debt/Equity Ratio22.7%

How did A142760 perform over the long term?

See historical performance and comparison